Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-DIS: Trabectedin Continuation vs Intermittent Therapy in Advanced Soft Tissue Sarcoma
NCT01303094Phase 2Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Feb 2011
- Primary completion
- May 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in soft tissue sarcoma (STS), uterine sarcoma, sponsored by Centre Oscar Lambret. Started Feb 2011; status: completed.
02
Drugs
trabectedin
03
Conditions
soft tissue sarcoma (STS)uterine sarcoma
Beyond the preview
Go deeper on NCT01303094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01303094.